BRPI1008936A2 - método in vitro para detectar pré-disposição, diagnóstico e /ou prognóstico de fibrose e método de seleção de um composto terapêutico - Google Patents
método in vitro para detectar pré-disposição, diagnóstico e /ou prognóstico de fibrose e método de seleção de um composto terapêuticoInfo
- Publication number
- BRPI1008936A2 BRPI1008936A2 BRPI1008936A BRPI1008936A BRPI1008936A2 BR PI1008936 A2 BRPI1008936 A2 BR PI1008936A2 BR PI1008936 A BRPI1008936 A BR PI1008936A BR PI1008936 A BRPI1008936 A BR PI1008936A BR PI1008936 A2 BRPI1008936 A2 BR PI1008936A2
- Authority
- BR
- Brazil
- Prior art keywords
- predisposition
- prognosis
- diagnosis
- selecting
- therapeutic compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09305159A EP2221387A1 (en) | 2009-02-19 | 2009-02-19 | Fibrosis susceptibility gene and uses thereof |
EP093051597 | 2009-02-19 | ||
PCT/EP2010/052048 WO2010094740A1 (en) | 2009-02-19 | 2010-02-18 | Fibrosis susceptibility gene and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI1008936A2 true BRPI1008936A2 (pt) | 2016-10-11 |
BRPI1008936B1 BRPI1008936B1 (pt) | 2021-04-06 |
BRPI1008936B8 BRPI1008936B8 (pt) | 2021-07-27 |
Family
ID=40568438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1008936A BRPI1008936B8 (pt) | 2009-02-19 | 2010-02-18 | método in vitro para detectar pré-disposição para ou diagnóstico e/ou prognóstico de fibrose hepática ou cirrose ocorrendo em um indivíduo humano |
Country Status (8)
Country | Link |
---|---|
US (2) | US9297044B2 (pt) |
EP (2) | EP2221387A1 (pt) |
JP (2) | JP5837825B2 (pt) |
KR (1) | KR101748679B1 (pt) |
CN (2) | CN105907843A (pt) |
BR (1) | BRPI1008936B8 (pt) |
CA (1) | CA2752802C (pt) |
WO (1) | WO2010094740A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012085217A1 (en) * | 2010-12-22 | 2012-06-28 | Universite De La Mediterranee (Aix-Marseille Ii) | A diagnostic method for dementias |
DK2739748T3 (da) * | 2011-08-05 | 2019-06-24 | Univ Aix Marseille | Il22ra2-gen med fibrosefølsomhed og anvendelser deraf |
ES2422874B1 (es) * | 2012-03-12 | 2014-07-15 | Universidad Autnoma De Madrid | Método in vitro de pronóstico de fibrosis hepática grave |
DK3607065T3 (da) * | 2017-04-06 | 2023-06-19 | Complete Omics Int Inc | Fremgangsmåde og kit til konstruktion af nukleinsyrebibliotek |
EP3425056A1 (en) * | 2017-07-07 | 2019-01-09 | Genepred Biotechnologies | Method for prognosing fibrosis progression |
EP3633474B1 (en) * | 2018-10-02 | 2022-04-06 | Tetra Laval Holdings & Finance S.A. | A system for controlling a manufacturing process for packaging units |
WO2020074727A1 (en) | 2018-10-11 | 2020-04-16 | Genepred Biotechnologies | Method for detecting fibrosis especially keloid |
CN111073884A (zh) * | 2020-02-14 | 2020-04-28 | 昆明理工大学 | 提高非编码区域距离<50bp的SNP中具有功能效应的SNP位点检测准确率的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
AU8126694A (en) | 1993-10-26 | 1995-05-22 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
US20030092019A1 (en) * | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
CN1589403B (zh) * | 2001-09-18 | 2011-06-01 | 法布罗根股份有限公司 | 测定结缔组织生长因子的方法 |
US7405274B2 (en) * | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
GB0326780D0 (en) * | 2003-11-18 | 2003-12-24 | Imp College Innovations Ltd | Biological materials and uses thereof |
CA2708004C (en) * | 2006-12-04 | 2015-12-01 | Promedior, Inc. | Conjoint therapy for treating fibrotic diseases |
US20130203054A1 (en) | 2010-05-04 | 2013-08-08 | Universite D'aix-Marseille | Antiviral treatment susceptibility gene and uses thereof |
DK2739748T3 (da) | 2011-08-05 | 2019-06-24 | Univ Aix Marseille | Il22ra2-gen med fibrosefølsomhed og anvendelser deraf |
-
2009
- 2009-02-19 EP EP09305159A patent/EP2221387A1/en not_active Withdrawn
-
2010
- 2010-02-18 KR KR1020117021902A patent/KR101748679B1/ko active IP Right Grant
- 2010-02-18 EP EP10703912.5A patent/EP2398911B1/en active Active
- 2010-02-18 CN CN201610204906.4A patent/CN105907843A/zh active Pending
- 2010-02-18 CA CA2752802A patent/CA2752802C/en active Active
- 2010-02-18 WO PCT/EP2010/052048 patent/WO2010094740A1/en active Application Filing
- 2010-02-18 US US13/201,520 patent/US9297044B2/en active Active
- 2010-02-18 JP JP2011550565A patent/JP5837825B2/ja active Active
- 2010-02-18 CN CN201080008683.5A patent/CN102325904B/zh active Active
- 2010-02-18 BR BRPI1008936A patent/BRPI1008936B8/pt active IP Right Grant
-
2015
- 2015-08-21 JP JP2015164050A patent/JP2016047045A/ja active Pending
-
2016
- 2016-02-16 US US15/045,107 patent/US20160230232A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102325904A (zh) | 2012-01-18 |
EP2398911B1 (en) | 2017-10-18 |
EP2398911A1 (en) | 2011-12-28 |
JP2016047045A (ja) | 2016-04-07 |
US20160230232A1 (en) | 2016-08-11 |
BRPI1008936B1 (pt) | 2021-04-06 |
CA2752802C (en) | 2018-04-03 |
WO2010094740A1 (en) | 2010-08-26 |
CA2752802A1 (en) | 2010-08-26 |
US9297044B2 (en) | 2016-03-29 |
JP5837825B2 (ja) | 2015-12-24 |
BRPI1008936B8 (pt) | 2021-07-27 |
CN102325904B (zh) | 2016-03-30 |
JP2012524520A (ja) | 2012-10-18 |
US20120135403A1 (en) | 2012-05-31 |
KR20120004971A (ko) | 2012-01-13 |
CN105907843A (zh) | 2016-08-31 |
KR101748679B1 (ko) | 2017-07-03 |
EP2221387A1 (en) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008936A2 (pt) | método in vitro para detectar pré-disposição, diagnóstico e /ou prognóstico de fibrose e método de seleção de um composto terapêutico | |
IL246042A0 (en) | Methods and systems for evaluating clinical expenses | |
IL219210A0 (en) | Biomarkers and methods for measuring and monitoring inflammatory disease activity | |
NO20085322L (no) | Fremgangsmate for raskere ansiktsdeteksjon | |
BRPI0923748A2 (pt) | Método para a preparação de dióis | |
BRPI0815725A2 (pt) | Métodos para detecção de oligonucleotídeos | |
ZA201102070B (en) | Method for evaluation,design and optimization of in-situ bioconversion processes | |
BRPI0822112A8 (pt) | sensor, método para detecção e método para produzir um sensor | |
DK2368118T3 (da) | Biomarkører til inhibitorer med anti-angiogen aktivitet | |
BRPI1015922A2 (pt) | sistemas e métodos para testar analitos | |
BR112012018103A2 (pt) | método para detectar a presença de uma amostra de testemunhagem dentro de uma ferramenta de testemunhagem, método para perfurar dentro de um poço com uma ferramenta de testemunhagem, e método para detectar a presença de uma amostra de testemunhagem dentro de uma ferramenta de testemunhagem | |
EP2142217A4 (en) | PCSK9 DETECTION METHOD SECRETED, SELF-GENERATED | |
BR112013011984A2 (pt) | composto, composição farmacêutica, e, métodos para fabricar um composto, para formação de imagem e para detectar agregados tau in vitro e/ou in vivo | |
HUE051130T2 (hu) | Eljárások szimmetrikus dimetilarginin kimutatására | |
BRPI0911371A2 (pt) | método de determinação do prognóstico de funcionamento de um sistema | |
BR112012014678A2 (pt) | "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" | |
IL248334A0 (en) | A method for the detection, quantification and mapping of damage and/or repair of DNA strands | |
EP2628005A4 (en) | BIOMARKERS AND METHOD FOR DETECTING A CHRONIC INFLAMMATORY DISEASE | |
BRPI0918744A2 (pt) | Metodo para produção de açúcar | |
BRPI0924560A2 (pt) | Métodos e kits para detectar, diagnosticar e monitorar doenças | |
GB2481002B (en) | Determining layer thickness | |
FR2945060B1 (fr) | Cassette pour revetement de facade, ensemble et revetement de facade correspondants | |
BRPI0912766A2 (pt) | método de diagnóstico de rolete | |
ZA201204405B (en) | Assay for quantifying neurotoxin | |
FI20116061A (fi) | Entsyymi, jolla on alfa-glukuronidaasiaktiivisuutta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA REC |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/02/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |